Cell Signaling Technology

GGA3 (D66F1) Rabbit Monoclonal Antibody

#8027 · $161

100
Citing papers
6.7k
Combined citations
Supplier page Find this product

Research areas

Cancer-related molecular mechanisms research14Circular RNAs in diseases9PI3K/AKT/mTOR signaling in cancer9RNA modifications and cancer8Cell death mechanisms and regulation8RNA Research and Splicing7Wnt/β-catenin signaling in development and cancer7MicroRNA in disease regulation6

Papers citing this product

1
Nephrin and CD2AP Associate with Phosphoinositide 3-OH Kinase and Stimulate AKT-Dependent Signaling
Molecular and Cellular Biology·2003·405 cit.·DOI
2
Non-viral precision T cell receptor replacement for personalized cell therapy
Nature·2022·270 cit.·DOI
3
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
British Journal of Cancer·2003·256 cit.·DOI
4
LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling
Cell Death and Disease·2018·242 cit.·DOI
5
Mammalian Target of Rapamycin Complex 1 Suppresses Lipolysis, Stimulates Lipogenesis, and Promotes Fat Storage
Diabetes·2010·227 cit.·DOI
6
Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion
Molecular Cancer·2018·216 cit.·DOI
7
Systematic Mapping of WNT-FZD Protein Interactions Reveals Functional Selectivity by Distinct WNT-FZD Pairs
Journal of Biological Chemistry·2015·186 cit.·DOI
8
Biomarkers of inflammation and repair in kidney disease progression
Journal of Clinical Investigation·2020·182 cit.·DOI
9
An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
EMBO Molecular Medicine·2015·180 cit.·DOI
10
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
Signal Transduction and Targeted Therapy·2022·177 cit.·DOI

Similar products

ProductVendorPricePapers
GGA3 AntibodyRabbitCell Signaling Technology$317100